ELI LILLY & Co is 4.8x more valuable than GSK plc by market capitalization ($1.070 T vs $220.82 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LLY | GSK |
|---|---|---|
| Market cap | $1.070 T | $220.82 B |
| US-listed rank | #10 | #62 |
| Revenue (latest FY) | $65.18B | - |
| Net income (latest FY) | $20.64B | - |
| Net margin | 31.7% | - |
| P/E (trailing FY) | 51.8 | - |
| SEC filings | 989 | 988 |
ELI LILLY & Co is 4.8x more valuable than GSK plc by market capitalization ($1.070 T vs $220.82 B).
Full pages: ELI LILLY & Co and GSK plc, or browse the full rankings.